Prague Med. Rep. 2022, 123, 266-278

https://doi.org/10.14712/23362936.2022.25

Pervitin Intoxication with Two-peak Massive Myoglobinemia, Acute Kidney Injury and Marked Procalcitonin Increase Not Associated with Sepsis

Eva Svobodová1, Tomáš Drábek2, Helena Brodská3

1Department of Anesthesiology and Intensive Care Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
2Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh School of Medicine and UPMC, Pittsburgh, United States
3Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic

Received May 31, 2022
Accepted October 18, 2022

References

1. Amyot, S. L., Leblanc, M., Thibeault, Y., Geadah, D., Cardinal, J. (1999) Myoglobin clearance and removal during continuous venovenous hemofiltration. Intensive Care Med. 25(10), 1169–1172. <https://doi.org/10.1007/s001340051031>
2. Andreu, V., Mas, A., Bruguera, M., Salmeron, J. M., Moreno, V., Nogue, S., Rodes, J. (1998) Ecstasy: A common cause of severe acute hepatotoxicity. J. Hepatol. 29(3), 394–397. <https://doi.org/10.1016/S0168-8278(98)80056-1>
3. Baradhi, K. M., Pathireddy, S., Bose, S., Aeddula, N. R. (2019) Methamphetamine (N-methylamphetamine)-induced renal disease: Underevaluated cause of end-stage renal disease (ESRD). BMJ Case Rep. 12(9), e230288. <https://doi.org/10.1136/bcr-2019-230288>
4. Bosch, X., Poch, E., Grau, J. M. (2009) Rhabdomyolysis and acute kidney injury. N. Engl. J. Med. 361(1), 62–72. <https://doi.org/10.1056/NEJMra0801327>
5. Defalque, R. J., Wright, A. J. (2011) Methamphetamine for Hitler’s Germany: 1937 to 1945. Bull. Anesth. Hist. 29(2), 21–24, 32. <https://doi.org/10.1016/S1522-8649(11)50016-2>
6. Demirkiran, M., Jankovic, J., Dean, J. M. (1996) Ecstasy intoxication: An overlap between serotonin syndrome and neuroleptic malignant syndrome. Clin. Neuropharmacol. 19(2), 157–164. <https://doi.org/10.1097/00002826-199619020-00004>
7. Dilken, O., Ince, C., van der Hoven, B., Thijsse, S., Ormskerk, P., de Geus, H. R. H. (2020) Successful reduction of creatine kinase and myoglobin levels in severe rhabdomyolysis using extracorporeal blood purification (CytoSorb®). Blood Purif. 49(6), 743–747. <https://doi.org/10.1159/000505899>
8. Dixit, D., Shrestha, P., Adelman, M. (2013) Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: Should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting? BMJ Case Rep. 2013, bcr2013010133.
9. Foley, R. J., Kapatkin, K., Verani, R., Weinman, E. J. (1984) Amphetamine-induced acute renal failure. South. Med. J. 77(2), 258–260. <https://doi.org/10.1097/00007611-198402000-00035>
10. Grunau, B. E., Wiens, M. O., Brubacher, J. R. (2010) Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review. CJEM 12(5), 435–442. <https://doi.org/10.1017/S1481803500012598>
11. Gurel, A. (2016) Multisystem toxicity after methamphetamine use. Clin. Case Rep. 4(3), 226–227. <https://doi.org/10.1002/ccr3.487>
12. Hall, A. P., Henry, J. A. (2006) Acute toxic effects of “Ecstasy” (MDMA) and related compounds: Overview of pathophysiology and clinical management. Br. J. Anaesth. 96(6), 678–685. <https://doi.org/10.1093/bja/ael078>
13. Hu, L., Shi, Q., Shi, M., Liu, R., Wang, C. (2017) Diagnostic value of PCT and CRP for detecting serious bacterial infections in patients with fever of unknown origin: A systematic review and meta-analysis. Appl. Immunohistochem. Mol. Morphol. 25(8), e61–e69. <https://doi.org/10.1097/PAI.0000000000000552>
14. Isoardi, K. Z., Ayles, S. F., Harris, K., Finch, C. J., Page, C. B. (2019) Methamphetamine presentations to an emergency department: Management and complications. Emerg. Med. Australas. 31(4), 593–599. <https://doi.org/10.1111/1742-6723.13219>
15. Isoardi, K. Z., Mudge, D. W., Harris, K., Dimeski, G., Buckley, N. A. (2020) Methamphetamine intoxication and acute kidney injury: A prospective observational case series. Nephrology (Carlton) 25(10), 758–764. <https://doi.org/10.1111/nep.13762>
16. Khatri, P., Neupane, A., Sapkota, S. R., Bashyal, B., Sharma, D., Chhetri, A., Chirag, K. C., Banjade, A., Sapkota, P., Bhandari, S. (2021) Strenuous exercise-induced tremendously elevated transaminases levels in a healthy adult: A diagnostic dilemma. Case Reports Hepatol. 2021, 6653266. <https://doi.org/10.1155/2021/6653266>
17. Kodama, S., Kashiura, M., Moriya, T. (2021) Procalcitonin elevation induced by sympathomimetic drug overdose. Acute Med. Surg. 8(1), e687. <https://doi.org/10.1002/ams2.687>
18. Krause, T., Gerbershagen, M. U., Fiege, M., Weisshorn, R., Wappler, F. (2004) Dantrolene – A review of its pharmacology, therapeutic use and new developments. Anaesthesia 59(4), 364–373. <https://doi.org/10.1111/j.1365-2044.2004.03658.x>
19. Kunitz, O., Ince, A., Kuhlen, R., Rossaint, R. (2003) Hyperpyrexia and rhabdomyolysis after ecstasy (MDMA) intoxication. Anaesthesist 52(6), 511–515. (in German) <https://doi.org/10.1007/s00101-003-0474-2>
20. Levine, J., Rinkel, M., Greenblatt, M. (1948) Psychological and physiological effects of intravenous pervitin. Am. J. Psychiatry 105(6), 429–434. <https://doi.org/10.1176/ajp.105.6.429>
21. Lim, A. K. H., Azraai, M., Pham, J. H., Looi, W. F., Bennett, C. (2020) The association between illicit drug use and the duration of renal replacement therapy in patients with acute kidney injury from severe rhabdomyolysis. Front. Med. (Lausanne) 7, 588114. <https://doi.org/10.3389/fmed.2020.588114>
22. Lovas, A., Agoston, Z., Kesmarky, K., Hankovszky, P., Molnar, Z. (2014) Extreme procalcitonin elevation without proven bacterial infection related to amphetamine abuse. Case Rep. Crit. Care 2014, 179313.
23. Moon, J., Cros, J. (2007) Role of dantrolene in the management of the acute toxic effects of Ecstasy (MDMA). Br. J. Anaesth. 99(1), 146. <https://doi.org/10.1093/bja/aem154>
24. Moresco, E., Rugg, C., Strohle, M., Thoma, M. (2022) Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb®) – A case report. Clin. Case Rep. 10(1), e05272. <https://doi.org/10.1002/ccr3.5272>
25. Musselman, M. E., Saely, S. (2013) Diagnosis and treatment of drug-induced hyperthermia. Am. J. Health Syst. Pharm. 70(1), 34–42. <https://doi.org/10.2146/ajhp110543>
26. O’Connor, A. D., Padilla-Jones, A., Gerkin, R. D., Levine, M. (2015) Prevalence of rhabdomyolysis in sympathomimetic toxicity: A comparison of stimulants. J. Med. Toxicol. 11(2), 195–200. <https://doi.org/10.1007/s13181-014-0451-y>
27. Penn, A. S., Rowland, L. P., Fraser, D. W. (1972) Drugs, coma, and myoglobinuria. Arch. Neurol. 26(4), 336–343. <https://doi.org/10.1001/archneur.1972.00490100066006>
28. Pettersson, J., Hindorf, U., Persson, P., Bengtsson, T., Malmqvist, U., Werkstrom, V., Ekelund, M. (2008) Muscular exercise can cause highly pathological liver function tests in healthy men. Br. J. Clin. Pharmacol. 65(2), 253–259. <https://doi.org/10.1111/j.1365-2125.2007.03001.x>
29. Richards, J. R., Johnson, E. B., Stark, R. W., Derlet, R. W. (1999) Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am. J. Emerg. Med. 17(7), 681–685. <https://doi.org/10.1016/S0735-6757(99)90159-6>
30. Rogliano, P. F., Voicu, S., Labat, L., Deye, N., Malissin, I., Laplanche, J. L., Vodovar, D., Megarbane, B. (2020) Acute poisoning with rhabdomyolysis in the intensive care unit: Risk factors for acute kidney injury and renal replacement therapy requirement. Toxics 8(4), 79. <https://doi.org/10.3390/toxics8040079>
31. Russell, T., Riazi, S., Kraeva, N., Steel, A. C., Hawryluck, L. A. (2012) Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. Anaesthesia 67(9), 1021–1024. <https://doi.org/10.1111/j.1365-2044.2012.07226.x>
32. Scandling, J., Spital, A. (1982) Amphetamine-associated myoglobinuric renal failure. South. Med. J. 75(2), 237–240. <https://doi.org/10.1097/00007611-198202000-00033>
33. Scharf, C., Liebchen, U., Paal, M., Irlbeck, M., Zoller, M., Schroeder, I. (2021) Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis. Crit. Care 25(1), 41. <https://doi.org/10.1186/s13054-021-03468-x>
34. Schein, J., Goolker, P. (1951) A preliminary report on the use of d-desoxyephedrine hydrochloride in the study of psychopathology and psychotherapy. Am. J. Psychiatry 107(11), 850–855. <https://doi.org/10.1176/ajp.107.11.850>
35. Seblova, J., Polanecky, V., Sejda, J., Studnickova, B. (2005) Trends in substance abuse by teenagers in the Czech Republic. J. Emerg. Med. 28(1), 95–100. <https://doi.org/10.1016/j.jemermed.2004.05.010>
36. Sejda, J., Studnickova, B., Polanecky, V. (1998) Trends in the incidence of problematic drug addicts in the Czech Republic, 1995–1996. Cent. Eur. J. Public Health 6(1), 18–24.
37. Terada, Y., Shinohara, S., Matui, N., Ida, T. (1988) Amphetamine-induced myoglobinuric acute renal failure. Jpn. J. Med. 27(3), 305–308. <https://doi.org/10.2169/internalmedicine1962.27.305>
38. Weidhase, L., de Fallois, J., Haussig, E., Kaiser, T., Mende, M., Petros, S. (2020) Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: A prospective randomized controlled trial. Crit. Care 24(1), 644. <https://doi.org/10.1186/s13054-020-03366-8>
39. Zarlasht, F., Salehi, M., Sattar, A., Abu-Hishmeh, M., Khan, M. (2017) Short-term high-dose steroid therapy in a case of rhabdomyolysis refractory to intravenous fluids. Am. J. Case Rep. 18, 1110–1113. <https://doi.org/10.12659/AJCR.905196>
40. Zeng, X., Zhang, L., Wu, T., Fu, P. (2014) Continuous renal replacement therapy (CRRT) for rhabdomyolysis. Cochrane Database Syst. Rev. 6, CD008566.
41. Zhang, L., Kang, Y., Fu, P., Cao, Y., Shi, Y., Liu, F., Hu, Z., Su, B., Tang, W., Qin, W. (2012) Myoglobin clearance by continuous venous-venous haemofiltration in rhabdomyolysis with acute kidney injury: a case series. Injury 43(5), 619–623. <https://doi.org/10.1016/j.injury.2010.08.031>
42. Zuberi, M., Guru, P. K., Bansal, V., Diaz-Gomez, J., Grieninger, B., Alejos, D. (2019) Undifferentiated shock and extreme elevation of procalcitonin related to kratom use. Indian J. Crit. Care Med. 23(5), 239–241.
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive